Terms: = Kidney tumors AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
8 results:
1. Comparison of second-line treatments in metastatic renal cell carcinoma patients: A single-center experience.
Pehlivan M; Paksoy N; Aydin E; Basaran M; Ekenel M
Medicine (Baltimore); 2023 Oct; 102(41):e35245. PubMed ID: 37832108
[TBL] [Abstract] [Full Text] [Related]
2. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.
Bearrick EN; Packiam V; Bhindi B; Lohse CM; Cheville JC; Mason RJ; Tollefson M; Harrington S; Dong H; Parker AS; Boorjian SA; Thompson RH; Leibovich BC
Urol Oncol; 2021 Feb; 39(2):135.e1-135.e8. PubMed ID: 33309297
[TBL] [Abstract] [Full Text] [Related]
3. Collaborative Molecular Epidemiology Study of Metabolic Dysregulation, DNA Methylation, and Breast Cancer Risk Among Nigerian Women: MEND Study Objectives and Design.
Akinyemiju T; Salako O; Daramola A; Alatise O; Adeniyi A; Ogun G; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Ojo A; Tollefsbol T; Arnett D
J Glob Oncol; 2019 Jun; 5():1-9. PubMed ID: 31194608
[TBL] [Abstract] [Full Text] [Related]
4. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
[TBL] [Abstract] [Full Text] [Related]
5. Childhood nephroblastoma in Southern and Eastern Europe and the US: Incidence variations and temporal trends by human development index.
Doganis D; Panagopoulou P; Tragiannidis A; Georgakis MK; Moschovi M; Polychronopoulou S; Rigatou E; Papakonstantinou E; Stiakaki E; Dana H; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Ryzhov A; Sekerija M; Trojanowski M; Zagar T; Zborovskaya A; Perisic SZ; Stefanaki K; Dessypris N; Petridou ET
Cancer Epidemiol; 2018 Jun; 54():75-81. PubMed ID: 29655086
[TBL] [Abstract] [Full Text] [Related]
6. KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.
Cocco E; Leo M; Canzonetta C; Di Vito S; Mai A; Rotili D; Di Napoli A; Vecchione A; De Nunzio C; Filetici P; Stoppacciaro A
Clin Epigenetics; 2018; 10():44. PubMed ID: 29632619
[TBL] [Abstract] [Full Text] [Related]
7. Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma.
Yu Q; Liu Y; Zheng X; Zhu Q; Shen Z; Wang H; He H; Lin N; Jiang H; Yu L; Zeng S
Drug Metab Dispos; 2017 Jan; 45(1):109-117. PubMed ID: 27821436
[TBL] [Abstract] [Full Text] [Related]
8. L-arginine-glycine amidinotransferase, betaine-homocysteine S-methyltransferase, and neuropolypeptide H3 are diminished in renal clear cell carcinoma of humans.
Peng JP; Zhang J; Huang HW; Wang FH; Du XJ; Luo PC
Saudi Med J; 2011 May; 32(5):467-73. PubMed ID: 21556466
[TBL] [Abstract] [Full Text] [Related]
